Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Penelope Pfeiffer, Joan R. Coates, Yajaira M. Esqueda, Andrew Kennedy, Kyleigh Getchell, Myra McLenon, Edina Kosa & Abdulbaki Agbas. (2023) Exosomal TAR DNA binding protein 43 profile in canine model of amyotrophic lateral sclerosis: a preliminary study in developing blood-based biomarker for neurodegenerative diseases. Annals of Medicine 55:1, pages 34-41.
Read now
Read now
Jaime Raymond, BjÖrn Oskarsson, Paul Mehta & Kevin Horton. (2019) Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 413-420.
Read now
Read now
Lisa A. van der Kleij, Ashley R. Jones, I Nick Steen, Carolyn A. Young, Pamela J. Shaw, Christopher E. Shaw, P. Nigel Leigh, Martin R. Turner & Ammar Al-Chalabi. (2015) Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 442-447.
Read now
Read now
John Ravits, Stanley Appel, Robert H. Baloh, Richard Barohn, Benjamin Rix Brooks, Lauren Elman, Mary Kay Floeter, Christopher Henderson, Catherine Lomen-Hoerth, Jeffrey D. Macklis, Leo McCluskey, Hiroshi Mitsumoto, Serge Przedborski, Jeffrey Rothstein, John Q. Trojanowski, Leonard H. van den Berg & Steven Ringel. (2013) Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup1, pages 5-18.
Read now
Read now
Matthew S. Devine, Helen Woodhouse, Pam A. McCombe & Robert D. Henderson. (2013) The relationship between limb dominance, disease lateralization and spread of weakness in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:2, pages 150-151.
Read now
Read now
Articles from other publishers (43)
Giammarco Milella, Stefano Zoccolella, Daniele Urso, Salvatore Nigro, Ludovica Tamburrino, Valentina Gnoni, Marco Filardi & Giancarlo Logroscino. (2023) Different patterns of spreading direction and motor neurons involvement in a cohort of limb‐onset amyotrophic lateral sclerosis patients from Southern Italy: Potential implication on disease course or progression?. Brain and Behavior 13:6.
Crossref
Crossref
Min Cheol Chang, Sang Gyu Kwak, Jin-Mo Park, Donghwi Park & Jin-Sung Park. (2022) Clinical and electrophysiological characteristics of respiratory onset amyotrophic lateral sclerosis: a single-centre study. Acta Neurologica Belgica 123:2, pages 391-397.
Crossref
Crossref
Tianmi Yang, Qianqian Wei, Chunyu Li, Bei Cao, Ruwei Ou, Yanbing Hou, Lingyu Zhang, Xiaojing Gu, Kuncheng Liu, Junyu Lin, Yangfan Cheng, Zheng Jiang, Jing Yang, Simin Kang, Meng Zhang, Yi Xiao, Bi Zhao, Yongping Chen, Xueping Chen & Huifang Shang. (2022) Spatial–temporal pattern of propagation in amyotrophic lateral sclerosis and effect on survival: A cohort study. European Journal of Neurology 29:11, pages 3177-3186.
Crossref
Crossref
Sneha Pandya, Pedro D. Maia, Benjamin Freeze, Ricarda A. L. Menke, Kevin Talbot, Martin R. Turner & Ashish Raj. (2022) Modeling seeding and neuroanatomic spread of pathology in amyotrophic lateral sclerosis. NeuroImage 251, pages 118968.
Crossref
Crossref
Zhengqing He, Bo Sun, Feng Feng, Jiongming Bai, Haoran Wang, Hongfen Wang, Fei Yang, Fang Cui & Xusheng Huang. (2021) Time of symptoms beyond the bulbar region predicts survival in bulbar onset amyotrophic lateral sclerosis. Neurological Sciences 43:3, pages 1817-1822.
Crossref
Crossref
David Burke. (2022) Neurophysiological Testing in the Diagnosis of Amyotrophic Lateral Sclerosis. Neurological Sciences and Neurophysiology 39:1, pages 1-7.
Crossref
Crossref
MariaN Zakharova & AnnaA Abramova. (2022) Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis. Neural Regeneration Research 17:1, pages 65.
Crossref
Crossref
Graziella Donatelli, Mauro Costagli, Paolo Cecchi, Gianmichele Migaleddu, Francesca Bianchi, Paolo Frumento, Gabriele Siciliano & Mirco Cosottini. (2022) Motor cortical patterns of upper motor neuron pathology in amyotrophic lateral sclerosis: A 3 T MRI study with iron-sensitive sequences. NeuroImage: Clinical 35, pages 103138.
Crossref
Crossref
Estela Area-Gomez, D. Larrea, T. Yun, Y. Xu, J. Hupf, F. Zandkarimi, R. B. Chan & H. Mitsumoto. (2021) Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders. Scientific Reports 11:1.
Crossref
Crossref
Kaila L. Stipancic, Yana Yunusova, Thomas F. Campbell, Jun Wang, James D. Berry & Jordan R. Green. (2021) Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 12.
Crossref
Crossref
Maria Elena Cicardi, Lara Marrone, Mimoun Azzouz & Davide Trotti. (2021) Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. The EMBO Journal 40:10.
Crossref
Crossref
Ritchie Ho, Michael J. Workman, Pranav Mathkar, Kathryn Wu, Kevin J. Kim, Jacqueline G. O’Rourke, Mariko Kellogg, Valerie Montel, Maria G. Banuelos, Olubankole Aladesuyi Arogundade, Sandra Diaz-Garcia, Daniel Oheb, Steven Huang, Irina Khrebtukova, Lisa Watson, John Ravits, Kevin Taylor, Robert H. Baloh & Clive N. Svendsen. (2021) Cross-Comparison of Human iPSC Motor Neuron Models of Familial and Sporadic ALS Reveals Early and Convergent Transcriptomic Disease Signatures. Cell Systems 12:2, pages 159-175.e9.
Crossref
Crossref
T. Dharmadasa, J. Howells, J. M. Matamala, N. G. Simon, D. Burke, S. Vucic & M. C. Kiernan. (2020) Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis. European Journal of Neurology 28:1, pages 90-97.
Crossref
Crossref
Sanjay Das, A. Nalini, T. R. Laxmi & T. R. Raju. (2020) ALS-CSF-induced structural changes in spinal motor neurons of rat pups cause deficits in motor behaviour. Experimental Brain Research 239:1, pages 315-327.
Crossref
Crossref
Song-Jie LiaoZi HuangChong-Yuan LaiJing-Yan ChenPei-Yao XiaoQiong CaiJian Yu. (2020) The rostral to caudal gradient of clinical and electrophysiological features in sporadic amyotrophic lateral sclerosis with bulbar-onset. Journal of International Medical Research 48:9, pages 030006052095650.
Crossref
Crossref
Umberto Manera, Andrea Calvo, Margherita Daviddi, Antonio Canosa, Rosario Vasta, Maria Claudia Torrieri, Maurizio Grassano, Maura Brunetti, Sandra D'Alfonso, Lucia Corrado, Fabiola De Marchi, Cristina Moglia, Fabrizio D'Ovidio, Gabriele Mora, Letizia Mazzini & Adriano Chiò. (2020) Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry 91:3, pages 291-297.
Crossref
Crossref
S. Bräuer, V. Zimyanin & A. Hermann. (2018) Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis. Journal of Neural Transmission 125:4, pages 591-613.
Crossref
Crossref
Marcia H. Ratner, Joe F. Jabre, William M. Ewing, Mohamed Abou-Donia & L. Christine Oliver. (2018) Amyotrophic lateral sclerosis-A case report and mechanistic review of the association with toluene and other volatile organic compounds. American Journal of Industrial Medicine 61:3, pages 251-260.
Crossref
Crossref
Leila Bond, Kamren Bernhardt, Priyank Madria, Katherine Sorrentino, Hailee Scelsi & Cassie S. Mitchell. (2018) A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy. Frontiers in Neuroscience 12.
Crossref
Crossref
Francis Meire Fávero, Mariana Callil Voos, Isac de Castro, Fátima Aparecida Caromano & Acary Souza Bulle Oliveira. (2017) Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS. Arquivos de Neuro-Psiquiatria 75:8, pages 515-522.
Crossref
Crossref
Martin R Turner & Ricarda A L Menke. (2017) The tough body at the epicentre of amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 88:5, pages 369.2-370.
Crossref
Crossref
Neil G. Simon, Jim Lagopoulos, Sita Paling, Casey Pfluger, Susanna B. Park, James Howells, Thomas Gallagher, Michel Kliot, Robert D. Henderson, Steve Vucic & Matthew C. Kiernan. (2017) Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS. Journal of Neurology 264:5, pages 882-890.
Crossref
Crossref
M.J. Magnussen & J.D. Glass. 2017. Molecular and Cellular Therapies for Motor Neuron Diseases. Molecular and Cellular Therapies for Motor Neuron Diseases
25
41
.
Ricarda A. L. Menke, Federica Agosta, Julian Grosskreutz, Massimo Filippi & Martin R. Turner. (2016) Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 11-23.
Crossref
Crossref
Rosanna Tortelli, Massimiliano Copetti, Francesco Panza, Rosa Cortese, Rosa Capozzo, Eustachio D'Errico, Andrea Fontana, Isabella Laura Simone & Giancarlo Logroscino. (2016) Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis: Table 1. Journal of Neurology, Neurosurgery & Psychiatry 87:6, pages 678-679.
Crossref
Crossref
R. Tortelli, M. Copetti, F. Panza, A. Fontana, R. Cortese, R. Capozzo, A. Introna, E. D'Errico, S. Zoccolella, S. Arcuti, D. Seripa, I. L. Simone & G. Logroscino. (2016) Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study. European Journal of Neurology 23:6, pages 1117-1125.
Crossref
Crossref
Richard Smith, Kathleen Myers, John Ravits & Robert Bowser. (2015) Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread?. Medical Hypotheses 85:5, pages 576-583.
Crossref
Crossref
Mirian Conceicao Moura, Maria Rita Carvalho Garbi Novaes, Emanoel Junio Eduardo, Yuri S. S. P. Zago, Ricardo Del Negro Barroso Freitas & Luiz Augusto Casulari. (2015) Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study. PLOS ONE 10:10, pages e0141500.
Crossref
Crossref
Neil G. Simon, Michael Lee, Jong Seok Bae, Eneida Mioshi, Cindy S.-Y. Lin, Casey M. Pfluger, Robert D. Henderson, Steve Vucic, Michael Swash, David Burke & Matthew C. Kiernan. (2015) Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis. Journal of Neurology 262:6, pages 1424-1432.
Crossref
Crossref
Neta Zach, David L. Ennist, Albert A. Taylor, Hagit Alon, Alexander Sherman, Robert Kueffner, Jason Walker, Ervin Sinani, Igor Katsovskiy, Merit Cudkowicz & Melanie L. Leitner. (2015) Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?. Neurotherapeutics 12:2, pages 417-423.
Crossref
Crossref
Robert Küffner, Neta Zach, Raquel Norel, Johann Hawe, David Schoenfeld, Liuxia Wang, Guang Li, Lilly Fang, Lester Mackey, Orla Hardiman, Merit Cudkowicz, Alexander Sherman, Gokhan Ertaylan, Moritz Grosse-Wentrup, Torsten Hothorn, Jules van Ligtenberg, Jakob H Macke, Timm Meyer, Bernhard Schölkopf, Linh Tran, Rubio Vaughan, Gustavo Stolovitzky & Melanie L Leitner. (2014) Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nature Biotechnology 33:1, pages 51-57.
Crossref
Crossref
John Ravits. (2014) Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Experimental Neurology 262, pages 121-126.
Crossref
Crossref
Neil G. Simon, Catherine Lomen-Hoerth & Matthew C. Kiernan. (2014) Patterns of clinical and electrodiagnostic abnormalities in early amyotrophic lateral sclerosis. Muscle & Nerve 50:6, pages 894-899.
Crossref
Crossref
Christina Schuster, Elisabeth Kasper, Judith Machts, Daniel Bittner, Jörn Kaufmann, Reiner Benecke, Stefan Teipel, Stefan Vielhaber & Johannes Prudlo. (2014) Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis. Journal of Neurology 261:10, pages 1871-1880.
Crossref
Crossref
Matthew GladmanMelanie DeHaanHanika PintoWilliam GeertsLorne Zinman. (2014) Venous thromboembolism in amyotrophic lateral sclerosis. Neurology 82:19, pages 1674-1677.
Crossref
Crossref
Christina Schuster, Elisabeth Kasper, Judith Machts, Daniel Bittner, Jörn Kaufmann, Reiner Benecke, Stefan Teipel, Stefan Vielhaber & Johannes Prudlo. (2013) Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. Journal of Neurology 260:11, pages 2856-2864.
Crossref
Crossref
P. Bede, A. Bokde, M. Elamin, S. Byrne, R. L. McLaughlin, N. Jordan, H. Hampel, L. Gallagher, C. Lynch, A. J. Fagan, N. Pender & O. Hardiman. (2012) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. Journal of Neurology, Neurosurgery & Psychiatry 84:7, pages 766-773.
Crossref
Crossref
Neil G. Simon & Matthew C. Kiernan. (2013) Fasciculation anxiety syndrome in clinicians. Journal of Neurology 260:7, pages 1743-1747.
Crossref
Crossref
Martin R Turner & Kevin Talbot. (2013) Mimics and chameleons in motor neurone disease. Practical Neurology 13:3, pages 153-164.
Crossref
Crossref
Martin R Turner, Orla Hardiman, Michael Benatar, Benjamin R Brooks, Adriano Chio, Mamede de Carvalho, Paul G Ince, Cindy Lin, Robert G Miller, Hiroshi Mitsumoto, Garth Nicholson, John Ravits, Pamela J Shaw, Michael Swash, Kevin Talbot, Bryan J Traynor, Leonard H Van den Berg, Jan H Veldink, Steve Vucic & Matthew C Kiernan. (2013) Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology 12:3, pages 310-322.
Crossref
Crossref
G. M. Gargiulo‐Monachelli, F. Janota, M. Bettini, C. L. Shoesmith, M. J. Strong & R. E. P. Sica. (2012) Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. European Journal of Neurology 19:6, pages 834-841.
Crossref
Crossref
Tadashi Kanouchi, Teruhiko Sekiguchi, Hidehiro Mizusawa & Takanori Yokota. (2012) Whether or not ALS lesions spread contiguously?. Rinsho Shinkeigaku 52:11, pages 1059-1061.
Crossref
Crossref
Roger Pamphlett. (2011) The “somatic-spread” hypothesis for sporadic neurodegenerative diseases. Medical Hypotheses 77:4, pages 544-547.
Crossref
Crossref